Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Omaha, NE
NPI: 1174780126Primary Practice Location
Nebraska Medical Center
987400 Nebraska Medical Ctr, Omaha, NE
Primary Employer
Unmc Physicians
nebraskamed.com
HQ Phone
Get M.D. Sara's Phone NumberMobile
Get M.D. Sara's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
NE State Medical License
American Board of Internal Medicine
Infectious Disease
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 37 | 38 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 36 | 96 |
Authors: Anum Abbas, Mackenzie Keintz, Jasmine Marcelin
Journal: Open Forum Infect Dis
Publication Date: 2022-05-03
Authors: Spooner, Rachel K, Taylor, Brittany K, Moshfegh, Cassandra M, Ahmad, Iman M, Dyball, Kelsey N, Emanuel, Katy, Schlichte, Sarah L, Schantell, Mikki, May, Pamela E, O'Neill, Jennifer, Kubat, Maureen, Bares, Sara H, Swindells, Susan, Fox, Howard S, Stauch, Kelly L, Wilson, Tony W, Case, Adam J, Zimmerman, Matthew C
Journal: EBioMedicine
Publication Date: 2021-07-17
Authors: David Haas, Jordan Lake, Michael Leonard, Kristine Erlandson, John Koethe, Todd Hulgan, Todd Brown
Journal: Pharmacogenet Genomics
Publication Date: 2023-11-01
Lead Sponsor: ViiV Healthcare
Intervention / Treatment: DRUG: Placebo, DRUG: Dolutegravir, DRUG: ABC/3TC, DRUG: GSK3640254, DRUG: FTC/TAF
Lead Sponsor: ViiV Healthcare
Collaborators: Syneos Health
Intervention / Treatment: DRUG: Dolutegravir, DRUG: GSK3640254, DRUG: Lamivudine capsules, DRUG: Lamivudine tablets
Lead Sponsor: University of Colorado, Denver
Collaborators: Gilead Sciences
Intervention / Treatment: DRUG: bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF), DRUG: Standard initiation of antiretroviral therapy (ART)
